Abstract

Determination of impurity level in weight percent against the claimed active pharmaceutical ingredient (API) in a drug product is of critical importance in drug development. However, authentic material used to determine relative UV response factor (RRF) for impurity quantitation is sometimes not available or not stable. In a particular drug product liquid formulation, three degradants, including one unstable impurity, are consistently observed in stability studies. Here we describe the application of NMR spectroscopy to assist in the determination of RRFs, simultaneously, for all three degradants directly from degraded drug product extracts. This technique was not only effective in determining RRF of an unstable substance, but also in defining RRFs of multiple degradants from a single drug product sample. Overall, this study continues to demonstrate the capabilities of NMR for impurity quantitation in drug development.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.